The city of Seattle, Washington, currently has 1 active clinical trials seeking participants for Atopic Dermatitis research studies.
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
Recruiting
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/16/2024
Locations: Dermatology of Seattle & Bellevue, Seattle, Washington
Conditions: Atopic Dermatitis